Vaping to quit smoking: Qualitative study of people receiving opioid agonist treatment. [PDF]
Kypri K +8 more
europepmc +1 more source
Universal Health Coverage of Opioid Agonist Treatment in Norway: An Equity-Adjusted Economic Evaluation. [PDF]
Chaudhary P +4 more
europepmc +1 more source
Comparative effectiveness of alternative initial doses of opioid agonist treatment for individuals with opioid use disorder: a protocol for a retrospective population-based study using target trial emulation in British Columbia, Canada. [PDF]
Yan R +13 more
europepmc +1 more source
Examining opioid agonist treatment (OAT) site operations and early signals of change in the first year of British Columbia's drug decriminalization policy: Insights from a provincial survey. [PDF]
Russell C +9 more
europepmc +1 more source
Data Resource Profile Update: The Opioid Agonist Treatment and Safety II (OATS II) Study, 2001-22, New South Wales, Australia. [PDF]
Jones N +7 more
europepmc +1 more source
Clinical Outcomes of Benzodiazepine Prescribing for People Receiving Opioid Agonist Treatment: A Systematic Review of the Evidence. [PDF]
Matheson C +8 more
europepmc +1 more source
8. Opioid Agonist Maintenance Treatment in Central Asia
Uladzimir Pikirenia +3 more
openaire +1 more source
Related searches:
Injectable opioid agonist treatment: An evolutionary concept analysis
Research in Nursing & Health, 2021AbstractCanada is currently in the midst of an overdose crisis. With new and innovative approaches desperately needed, injectable opioid agonist treatment (iOAT) should be considered as an integral treatment option to prevent even more fatalities. These programs provide injectable diacetylmorphine or hydromorphone to clients with severe opioid use ...
Marlene Haines, Patrick O'Byrne
openaire +3 more sources

